Observational studyDrug design, development and therapy2026
Efficacy and Safety of Upadacitinib for Refractory Inflammatory Bowel Disease: A Multicenter Real-World Observational Study.
Yuqing Mao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.